• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

diabetes mellitus

Dorzagliatin: Drug That Can “Cure” Diabetes
Posted inClinical Trials, Metabolism

Dorzagliatin: Drug That Can “Cure” Diabetes

November 13, 2022November 13, 2022

Hua Medicine has figured out how to bring type 2 diabetes mellitus into long-term and sustained remission.

BCG Vaccination: Almost Absolute Protection Against COVID-19
Posted inClinical Trials, COVID-19, Infections

BCG Vaccination: Almost Absolute Protection Against COVID-19

August 22, 2022December 9, 2022

BCG is a universal vaccine that protects against SARS-CoV-2 coronavirus of any variant.

insulin
Posted inAutoimmune Diseases, Clinical Trials, Metabolism

Insulin Icodec: Basal Insulin Once a Week

August 6, 2022September 8, 2022

Novo Nordisk will offer a very patient-friendly weekly version of insulin.

weight-loss-pills
Posted inClinical Trials, In the Pipeline, Metabolism

Most Effective Weight Loss Drugs: Present and Future

July 3, 2022September 20, 2022

Modern pharmacological ways to combat obesity.

obesity
Posted inClinical Trials, Metabolism

Tirzepatide: Strong Weight-Loss Drug

June 6, 2022September 8, 2022

Losing 24 kilograms in a year and a half.

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Posted inMetabolism, New Drugs, Regulatory

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus

May 17, 2022September 8, 2022

Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.

Twymeeg: Completely New Drug for Treatment of Type 2 Diabetes Mellitus
Posted inMetabolism, New Drugs, Regulatory

Twymeeg: Completely New Drug for Treatment of Type 2 Diabetes Mellitus

February 17, 2022September 8, 2022

Imeglimin is a universal anti-diabetic drug that incorporates the power of all existing glucose-lowering drugs.

Posts navigation

1 2 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News